Article info

Trends, variation, and clinical characteristics of recipients of antiviral drugs and neutralising monoclonal antibodies for covid-19 in community settings: retrospective, descriptive cohort study of 23.4 million people in OpenSAFELY

Authors

  1. Correspondence to Brian MacKenna, Bennett Institute for Applied Data Science, University of Oxford Nuffield Department of Primary Care Health Sciences, Oxford, UK; brian.mackenna{at}phc.ox.ac.uk
View Full Text

Citation

Green ACA, Curtis HJ, Higgins R, et al
Trends, variation, and clinical characteristics of recipients of antiviral drugs and neutralising monoclonal antibodies for covid-19 in community settings: retrospective, descriptive cohort study of 23.4 million people in OpenSAFELY

Publication history

  • Received June 6, 2022
  • Accepted November 25, 2022
  • First published January 13, 2023.
Online issue publication 
January 13, 2023
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.